205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.73 | 5.46
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.29%
Revenue growth 5-10% – Moderate. Peter Lynch would evaluate product demand drivers to determine if growth can accelerate.
17.45%
Gross profit growth 15-20% – Strong. Benjamin Graham would check if inventory or receivables are climbing faster than sales.
99.20%
EBIT growth above 20% – Outstanding expansion in core profitability. Warren Buffett would confirm if operating margins also improve, not just top-line growth.
99.20%
Operating income growth above 20% – Elite operational improvement. Warren Buffett would check if margin expansion accompanies this growth.
269.42%
Net income growth above 25% – Exceptional bottom-line expansion. Benjamin Graham would check if accounting one-offs inflate results.
271.43%
EPS growth above 25% – Exceptional. Warren Buffett would double-check that it’s not solely driven by aggressive buybacks rather than real profit increases.
257.14%
Diluted EPS growth above 25% – Impressive performance. Warren Buffett would confirm if major buybacks or real profit improvements drive these gains.
-0.54%
Share count shrinking more than 10% – Aggressive buybacks. Warren Buffett typically welcomes this if undervalued, but watch debt usage for repurchases.
3.44%
Diluted share count growth above 3% – Noticeable dilution. Philip Fisher would question the rationale for issuing more stock or options.
0.54%
Dividend growth 0-2% – Barely rising. Howard Marks might question if the firm should allocate capital elsewhere.
34.92%
OCF growth above 20% – Exceptional cash generation improvement. Warren Buffett might see if the net margin also rises in tandem.
28.24%
FCF growth above 20% – Very attractive to value investors. Warren Buffett would check if capital expenditures remain sensible to maintain this level.
-3.87%
A negative 10Y CAGR in revenue/share implies a decade of top-line decline per share. Benjamin Graham would be extremely cautious about long-term viability.
8.86%
5Y CAGR 7-10% – Solid. Seth Klarman might check if free cash flow growth parallels top-line expansion.
-19.76%
Negative 3Y CAGR signals recent top-line contraction per share. Benjamin Graham would be skeptical unless a turnaround is clear.
64.67%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
-17.74%
A negative 5Y OCF/share CAGR indicates declining cash generation per share mid-term. Benjamin Graham would see this as a red flag unless explained by short-term strategic investments.
4.61%
3Y OCF/share CAGR 2-5% – Mild. Peter Lynch would look for near-term catalysts to accelerate OCF further.
151.10%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
147.51%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
-34.10%
Negative 3Y net income/share CAGR highlights recent bottom-line decay. Benjamin Graham would want clarity on cost vs. revenue drivers for the declines.
308.57%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
72.15%
5Y equity/share CAGR above 12% – Strong mid-term book value expansion. Warren Buffett would see if steady profits and moderate payout ratios sustain this pace.
-8.05%
Negative 3Y equity/share CAGR means a near-term drop in book value. Benjamin Graham would be cautious unless restructured operations promise a future rebound.
31.93%
10Y dividend/share CAGR above 15% – Remarkable long-term payout increases. Warren Buffett would confirm if these distributions are well-covered by free cash flow.
-1.18%
A negative 5Y dividend/share CAGR indicates cuts or stagnation. Benjamin Graham would see it as a warning unless the firm redirected funds to more profitable growth.
5.82%
3Y dividend/share CAGR 4-7% – Decent. Seth Klarman sees moderate improvement if it aligns with short-term profit uptrends.
5.69%
Receivables growth 0-10% – Typically normal if revenue grows at a similar pace. Seth Klarman verifies the AR-to-revenue ratio stays constant.
-0.50%
Negative inventory growth can boost near-term margins if sales remain stable. Benjamin Graham still checks that it’s not from falling demand.
3.09%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
5.01%
5-8% annual BV/share growth – Decent. Seth Klarman monitors if ROE supports continued expansions.
-4.68%
A negative growth rate in debt means deleveraging, often positive for conservative investors. Benjamin Graham confirms it doesn’t restrict needed investments.
10.38%
R&D growth 10-20% – Noticeable increase. Peter Lynch checks if big breakthroughs might justify near-term profit hits.
-4.57%
Shrinking SG&A can raise profits short term, but might risk cutting key growth drivers. Benjamin Graham sees if this is sustainable.